Novo Nordisk A/S Share Repurchase Programme Update

Novo Nordisk A/S announced an update on its share repurchase program. The program, initiated on February 4, 2026, is part of a larger initiative to repurchase up to DKK 15 billion worth of shares over a 12-month period. In the period from February 4, 2026, to May 4, 2026, Novo Nordisk plans to repurchase B shares amounting to up to DKK 3.8 billion. As of March 13, 2026, the company has repurchased 6,577,992 B shares, with a total transaction value of DKK 1,783,540,174, at an average price of DKK 271.14 per share. Following these transactions, Novo Nordisk holds 23,967,791 B shares as treasury shares, representing 0.5% of the total share capital. The company expects to complete the repurchase of B shares up to DKK 15 billion within the 12-month period commencing February 4, 2026.